HighMark Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.83K Buy
207
+19
+10% +$1.03K ﹤0.01% 335
2026
Q1
$11.8K Buy
188
+27
+17% +$2.16K ﹤0.01% 273
2025
Q4
$15.4K Hold
161
0.01% 268
2025
Q3
$15.7K Sell
161
-27
-14% -$2.8K 0.01% 258
2025
Q2
$20.2K Buy
188
+24
+15% +$2.43K 0.01% 222
2025
Q1
$16.5K Sell
164
-6
-4% -$604 0.01% 215
2024
Q4
$15.2K Sell
170
-11
-6% -$968 0.01% 235
2024
Q3
$15.2K Sell
181
-93
-34% -$7.33K 0.01% 237
2024
Q2
$21.1K Sell
274
-25
-8% -$1.83K 0.01% 198
2024
Q1
$20.5K Sell
299
-12
-4% -$772 0.01% 197
2023
Q4
$18K Hold
311
0.01% 200
2023
Q3
$16.4K Buy
311
+103
+50% +$5.4K 0.01% 198
2023
Q2
$11.3K Hold
208
0.01% 244
2023
Q1
$10.4K Buy
208
+43
+26% +$2.03K 0.01% 295
2022
Q4
$7.63K Buy
165
+120
+267% +$5.2K 0.01% 291
2022
Q3
$2K Hold
45
﹤0.01% 417
2022
Q2
$2K Hold
45
﹤0.01% 424
2022
Q1
$2K Hold
45
﹤0.01% 433
2021
Q4
$2K Hold
45
﹤0.01% 437
2021
Q3
$2K Hold
45
﹤0.01% 438
2021
Q2
$2K Hold
45
﹤0.01% 449
2021
Q1
$2K Sell
45
-146
-76% -$5.53K ﹤0.01% 416
2020
Q4
$7K Hold
191
0.01% 281
2020
Q3
$7K Hold
191
0.01% 265
2020
Q2
$7K Buy
191
+146
+324% +$5.26K 0.01% 258
2020
Q1
$1K Hold
45
﹤0.01% 320
2019
Q4
$2K Buy
+45
New +$1.88K ﹤0.01% 341

Other funds holding BSX

HighMark Wealth Management's BSX Position: Q2 2026 in Review

HighMark Wealth Management increased its Boston Scientific (BSX) stake by 10% in Q2 2026, buying an estimated $1.03K and bringing the position to 207 shares worth $8.83K. The position accounts for ﹤0.01% of the portfolio, ranked #335.

HighMark Wealth Management first reported a position in BSX in Q4 2019 and has held it in 27 quarters since. The position peaked at $21.1K in Q2 2024. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • HighMark Wealth Management held 207 shares of Boston Scientific worth $8.83K as of Q2 2026.
  • HighMark Wealth Management bought 19 Boston Scientific shares in Q2 2026, an estimated $1.03K.
  • Boston Scientific made up ﹤0.01% of HighMark Wealth Management's portfolio in Q2 2026, its #335 holding.
  • HighMark Wealth Management first reported a position in Boston Scientific in Q4 2019 and has held it in 27 quarters since.
  • HighMark Wealth Management's Boston Scientific position peaked at $21.1K in Q2 2024.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.